Back to all news
LSTM Deep Learning Enhances Optical Sensing for Biochemical and Medical Applications
Researchers have developed an LSTM-driven interferometric sensing system that achieves both high sensitivity and wide measurement range, overcoming previous trade-offs in optical sensing.
Key Details
- 1The LSTM model allows for accurate refractive index measurement beyond the free spectral range (FSR) limitation in optical interferometers.
- 2System architecture includes broadband light source, specially fabricated single-mode fiber, and spectral analyzer.
- 3Deep learning enables direct mapping of complex spectra to target measurements despite spectral overlap, tripling the detection range while retaining sensitivity.
- 4Efficient down-sampling reduces data acquisition and processing, making rapid, practical deployment feasible.
- 5Application relevance spans physics, chemistry, biology, and medicine—enabling real-time, high-precision monitoring in complex environments.
Why It Matters
This breakthrough demonstrates how advanced AI models like LSTM can significantly improve the capabilities of optical sensors used in medical and biochemical environments, potentially influencing future noninvasive diagnostic technologies. It highlights a practical pathway for AI-powered, high-precision sensing systems in challenging measurement scenarios.
Source
EurekAlert
Related News
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.